Joerg Felsberg

1.3k total citations
22 papers, 441 citations indexed

About

Joerg Felsberg is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Joerg Felsberg has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Joerg Felsberg's work include Glioma Diagnosis and Treatment (16 papers), Cancer Genomics and Diagnostics (5 papers) and Epigenetics and DNA Methylation (4 papers). Joerg Felsberg is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Cancer Genomics and Diagnostics (5 papers) and Epigenetics and DNA Methylation (4 papers). Joerg Felsberg collaborates with scholars based in Germany, Switzerland and United States. Joerg Felsberg's co-authors include Guido Reifenberger, Andreas von Deimling, Torsten Pietsch, Michael Weller, Christian Hartmann, Peter Roerig, Meinhard Hahn, Ralf P. Friedrich, Annegret Kunitz and Michael Wegner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Joerg Felsberg

19 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joerg Felsberg Germany	12	247	227	166	80	75	22	441
Roxanne Marshall United States	5	265 1.1×	199 0.9×	152 0.9×	87 1.1×	87 1.2×	6	433
Jethro Hu United States	13	295 1.2×	139 0.6×	112 0.7×	85 1.1×	93 1.2×	34	471
Teresia Kling Sweden	13	157 0.6×	329 1.4×	154 0.9×	49 0.6×	116 1.5×	23	532
Amithys Rahimian France	8	234 0.9×	192 0.8×	112 0.7×	67 0.8×	49 0.7×	10	379
Bracha Zelikovitch Israel	6	201 0.8×	337 1.5×	312 1.9×	69 0.9×	73 1.0×	10	509
Sarah Gaffey United States	9	243 1.0×	152 0.7×	87 0.5×	79 1.0×	148 2.0×	22	402
Guo-Shi Lin China	10	164 0.7×	183 0.8×	150 0.9×	39 0.5×	84 1.1×	12	408
Henning Leske Switzerland	10	160 0.6×	125 0.6×	79 0.5×	67 0.8×	85 1.1×	25	396
Kymberly K. Levine United States	3	238 1.0×	161 0.7×	134 0.8×	58 0.7×	102 1.4×	3	352
Angela A. van Tilborg Netherlands	5	163 0.7×	296 1.3×	136 0.8×	83 1.0×	70 0.9×	5	485

Countries citing papers authored by Joerg Felsberg

Since Specialization

Citations

This map shows the geographic impact of Joerg Felsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Felsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Felsberg more than expected).

Fields of papers citing papers by Joerg Felsberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Felsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Felsberg. The network helps show where Joerg Felsberg may publish in the future.

Co-authorship network of co-authors of Joerg Felsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Felsberg. A scholar is included among the top collaborators of Joerg Felsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Felsberg. Joerg Felsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yi, Xiao, Weigang Ge, Peter Blattmann, et al.. (2022). Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions. Neuro-Oncology. 25(2). 290–302. 15 indexed citations

Bauer, Elena K., Gabriele Stoffels, Tobias Blau, et al.. (2020). Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[ 18 F]-fluoroethyl)-L-tyrosine PET. Nuklearmedizin - NuclearMedicine. 1 indexed citations

Gobin, Matthieu, Petr V. Nazarov, Rolf Warta, et al.. (2019). A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications. Cancer Research. 79(6). 1226–1238. 26 indexed citations

Weller, Michael, Guido Reifenberger, Émilie Le Rhun, et al.. (2019). Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419).. Journal of Clinical Oncology. 37(15_suppl). 2056–2056. 1 indexed citations

Wimmer, Katharina, Martine Muleris, Olivier Lascols, et al.. (2018). Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6. European Journal of Human Genetics. 26(3). 440–444. 17 indexed citations

Weller, Michael, Bettina Hentschel, Dorothee Gramatzki, et al.. (2018). Differential elevation of TERT activity and sensitivity to temozolomide by type of TERT mutation in MGMT promoter-methylated glioblastoma.. Journal of Clinical Oncology. 36(15_suppl). 2013–2013.

Beseoglu, Kerim, Marcel A. Kamp, Igor Fischer, et al.. (2017). Fluorescence Behavior and Dural Infiltration of Meningioma Analyzed by 5-Aminolevulinic Acid–Based Fluorescence: Operating Microscope Versus Mini-Spectrometer. World Neurosurgery. 108. 118–127. 21 indexed citations

Brozou, Triantafyllia, Nan Qin, Jasmin Bartl, et al.. (2017). Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations. European Journal of Human Genetics. 26(1). 137–142. 16 indexed citations

Weller, Michael, Martin Sill, Bettina Hentschel, et al.. (2017). Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma.. Journal of Clinical Oncology. 35(15_suppl). 2013–2013. 1 indexed citations

10.

Weller, Michael, Bettina Hentschel, Kerstin Kaulich, et al.. (2016). EGFR gene amplification and variant III (EGFRvIII) mutation in primary and recurrent glioblastoma.. Journal of Clinical Oncology. 34(15_suppl). 2042–2042. 1 indexed citations

11.

Weller, Michael, Ruthild G. Weber, Edith Willscher, et al.. (2015). Molecular classification of diffuse cerebral gliomas using genome- and transcriptome-wide profiling.. Journal of Clinical Oncology. 33(15_suppl). 2007–2007.

12.

Weller, Michael, Ruthild G. Weber, Vera Riehmer, et al.. (2014). Do host factors determine long-term survival in glioblastoma? A genome/transcriptome profiling study by the German Glioma Network.. Journal of Clinical Oncology. 32(15_suppl). 2014–2014. 17 indexed citations

13.

Wiestler, Benedikt, David Capper, Volker Hovestadt, et al.. (2014). Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology. 16(12). 1630–1638. 64 indexed citations

14.

Wiestler, Benedikt, David Capper, Volker Hovestadt, et al.. (2014). Determining the glioma CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial.. Journal of Clinical Oncology. 32(15_suppl). 2017–2017. 3 indexed citations

15.

Weller, Michael, Kerstin Kaulich, Bettina Hentschel, et al.. (2013). Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. International Journal of Cancer. 134(10). 2437–2447. 98 indexed citations

16.

Tabatabai, Ghazaleh, Joerg Felsberg, Michael Sabel, et al.. (2012). Bevacizumab failure in glioblastomas.. Journal of Clinical Oncology. 30(15_suppl). 2067–2067. 4 indexed citations

17.

Waha, Anke, A Koch, Wolfgang Hartmann, et al.. (2007). SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas. Oncogene. 26(38). 5662–5668. 17 indexed citations

18.

Tews, Björn, Peter Roerig, Christian Hartmann, et al.. (2007). Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene. 26(34). 5010–5016. 35 indexed citations

19.

Schlierf, Beate, Ralf P. Friedrich, Peter Roerig, et al.. (2007). Expression of SoxE and SoxD genes in human gliomas. Neuropathology and Applied Neurobiology. 33(6). 621–630. 46 indexed citations

20.

Felsberg, Joerg, Christian Hartmann, Annegret Kunitz, et al.. (2006). Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling. International Journal of Cancer. 119(4). 792–800. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact